We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
+4.84%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$191B
AUM Growth
+$34.6B
Cap. Flow
+$29.9B
Cap. Flow %
15.69%
Top 10 Hldgs %
11.5%
Holding
3,667
New
211
Increased
2,098
Reduced
1,163
Closed
105

Top Buys

Rank Stock Value
1
TEAM icon
Atlassian
TEAM
+$905M
2
BMY icon
Bristol-Myers Squibb
BMY
+$786M
3
NVDA icon
NVIDIA
NVDA
+$736M
4
CNC icon
Centene
CNC
+$642M
5
AAPL icon
Apple
AAPL
+$451M

Top Sells

Rank Stock Value
1
MOH icon
Molina Healthcare
MOH
+$415M
2
INTC icon
Intel
INTC
+$329M
3
GM icon
General Motors
GM
+$237M
4
DASH icon
DoorDash
DASH
+$225M
5
INTU icon
Intuit
INTU
+$187M

Sector Composition

Rank Sector Weight
1 Technology 23.3%
2 Financials 15.19%
3 Healthcare 12.58%
4 Consumer Discretionary 12.42%
5 Industrials 12.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRLD icon
3626
Prelude Therapeutics
PRLD
$450M
-10,500
Closed -$15.1K
PRO
3627
DELISTED
PROS Holdings
PRO
-410,002
Closed -$9.39M
PVBC
3628
DELISTED
Provident Bancorp
PVBC
-21,353
Closed -$268K
PWB icon
3629
Invesco Large Cap Growth ETF
PWB
$2.39B
-2,641
Closed -$331K
PYXS icon
3630
Pyxis Oncology
PYXS
$159M
-13,832
Closed -$30.7K
QYLD icon
3631
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.27B
-11,106
Closed -$189K
REKR icon
3632
Rekor Systems
REKR
$93.6M
-17,450
Closed -$27.4K
RXRX icon
3633
Recursion Pharmaceuticals
RXRX
$1.79B
-14,910
Closed -$72.8K
SCPH
3634
DELISTED
scPharmaceuticals
SCPH
-13,567
Closed -$76.9K
SCS
3635
DELISTED
Steelcase
SCS
-298,499
Closed -$5.13M
SGC icon
3636
Superior Group of Companies
SGC
$204M
-12,694
Closed -$136K
SMP icon
3637
Standard Motor Products
SMP
$886M
-4,912
Closed -$201K
SPCE icon
3638
Virgin Galactic
SPCE
$492M
-10,488
Closed -$38.1K
SPNS
3639
DELISTED
Sapiens International
SPNS
-47,296
Closed -$2.03M
SPR
3640
DELISTED
Spirit AeroSystems
SPR
-175,888
Closed -$6.79M
SRDX
3641
DELISTED
Surmodics
SRDX
-19,610
Closed -$586K
STIP icon
3642
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
-2,103
Closed -$217K
SUSA icon
3643
iShares ESG Optimized MSCI USA ETF
SUSA
$4.16B
-1,928
Closed -$262K
TMCI icon
3644
Treace Medical Concepts
TMCI
$312M
-129,868
Closed -$871K
UHG
3645
DELISTED
United Homes Group
UHG
-20,500
Closed -$84.7K
VBTX
3646
DELISTED
Veritex Holdings
VBTX
-316,131
Closed -$10.6M
VKTX icon
3647
Viking Therapeutics
VKTX
$3.94B
-13,072
Closed -$334K
VMEO
3648
DELISTED
Vimeo
VMEO
-121,139
Closed -$939K
VRNT
3649
DELISTED
Verint Systems
VRNT
-401,028
Closed -$8.12M
VTLE
3650
DELISTED
Vital Energy
VTLE
-96,492
Closed -$1.63M

Similar funds

AQR Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, AQR Capital Management held 3,667 positions worth $191B, up 22% from $156B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

AQR Capital Management deployed $29.9B of net new capital in Q4 2025, opening 211 new positions and adding to 2,098 existing holdings. Its largest new stake was Celestica: 1,066,543 shares worth $315M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Molina Healthcare, an estimated $415M trimmed.

  • AQR Capital Management's largest Q4 2025 buy was Celestica: 1,066,543 shares worth $315M.
  • AQR Capital Management added most to Atlassian in Q4 2025, an estimated $905M increase.
  • AQR Capital Management's biggest Q4 2025 reduction was Molina Healthcare, cutting an estimated $415M.
  • AQR Capital Management fully exited Light & Wonder in Q4 2025, selling an estimated $70.7M.
  • AQR Capital Management's ten largest holdings make up 12% of its $191B portfolio in Q4 2025.
  • AQR Capital Management opened 211 new positions and closed 105 in Q4 2025.
  • AQR Capital Management's portfolio value rose 22% quarter-over-quarter to $191B.

Based on AQR Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.